{"id":"W4250523013","doi":"10.1016/j.annonc.2020.08.1139","title":"1019O Phase I studies of Sym021, an anti-PD-1 antibody, alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Immunogenicity; Tolerability; Adverse effect; Pharmacology; Pharmacokinetics; Oncology; Internal medicine; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008458816,0.001070184,0.001062257,0.0004063993,0.0003717542,0.0009625138,0.0006408686,0.001002806,0.009235677],"category_scores_gemma":[0.0003450479,0.0003280428,0.001017748,0.0003232069,0.0006122129,0.0004664531,0.0002436823,0.002979012,0.002548453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006180719,"about_ca_system_score_gemma":0.001213728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008708888,"about_ca_topic_score_gemma":0.002026092,"domain_scores_codex":[0.9997794,0.00007910209,0.00001064819,0.00003164656,0.00002742369,0.00007188199],"domain_scores_gemma":[0.9997594,0.00003603966,0.00002105092,0.00002117046,0.00001657763,0.000145765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4082758,0.1179759,0.003657323,0.001225924,0.001629128,0.0004150935,0.0002542073,0.005093008,0.1791185,0.001852224,0.02651434,0.2539886],"study_design_scores_gemma":[0.3176608,0.6254342,0.006185604,0.0000614807,0.0004582239,0.0004997526,0.00009548889,0.002685213,0.02690477,0.0005604332,0.0193948,0.0000590392],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737999,0.003617761,0.001355532,0.001125592,0.0008046775,0.002287986,0.003310354,0.0003538138,0.01334447],"genre_scores_gemma":[0.9554929,0.003142928,0.003571444,0.001588444,0.0003059178,0.002393316,0.01030891,0.00006957061,0.02312649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009235677,"threshold_uncertainty_score":0.03089643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.142296905195948,"score_gpt":0.4529135644197368,"score_spread":0.3106166592237889,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}